Phase II trial of docetaxel in non-Hodgkin's lymphomas: a study of the Cancer and Leukemia Group B. 1997 update of recommendations for the use of hematopoietic colony-stimulating factors: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results